Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety

Dual antiplatelet therapy, composed of aspirin plus a P2Y(12)-receptor antagonist, is the cornerstone of treatment for patients with acute coronary syndrome (ACS). A number of U.S. Food and Drug Administration–approved P2Y(12)-receptor antagonists are available for treating patients with ACS, includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobesh, Paul P, Oestreich, Julie H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Reviews of Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282310/
https://www.ncbi.nlm.nih.gov/pubmed/25164528
http://dx.doi.org/10.1002/phar.1477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282310/
https://www.ncbi.nlm.nih.gov/pubmed/25164528
http://dx.doi.org/10.1002/phar.1477

Ejemplares similares